These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38835814)

  • 1. Comparison of alpha-2 agonist versus alpha-1 antagonist for post-traumatic stress disorder-associated nightmares in pediatric patients.
    Khalid S; Mitchell S; Al-Mateen C
    Ment Health Clin; 2024 Jun; 14(3):199-203. PubMed ID: 38835814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review.
    Keeshin BR; Ding Q; Presson AP; Berkowitz SJ; Strawn JR
    Neurol Ther; 2017 Dec; 6(2):247-257. PubMed ID: 28755207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
    Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
    Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of low dose prazosin for PTSD-associated nightmares in children and adolescents.
    Hudson N; Burghart S; Reynoldson J; Grauer D
    Ment Health Clin; 2021 Mar; 11(2):45-49. PubMed ID: 33850681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prazosin treatment of nightmares related to posttraumatic stress disorder.
    Dierks MR; Jordan JK; Sheehan AH
    Ann Pharmacother; 2007 Jun; 41(6):1013-7. PubMed ID: 17504838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine for post-traumatic stress disorder: a systematic review of the current evidence.
    Marchi M; Grenzi P; Boks MP
    Eur J Psychotraumatol; 2024; 15(1):2366049. PubMed ID: 38941125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
    Taylor HR; Freeman MK; Cates ME
    Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder.
    George KC; Kebejian L; Ruth LJ; Miller CW; Himelhoch S
    J Trauma Dissociation; 2016; 17(4):494-510. PubMed ID: 26835889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-2 Agonists in Children and Adolescents With Post-traumatic Stress Disorder: A Systematic Review.
    Jagtiani A; Gandhi R; Banga A; Blacker J; Joshi R; Bollu B; Kashyap R
    Cureus; 2024 Jan; 16(1):e53009. PubMed ID: 38410304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares: A Systematic Review.
    Akinsanya A; Marwaha R; Tampi RR
    J Clin Psychopharmacol; 2017 Feb; 37(1):84-88. PubMed ID: 27930498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Prazosin for Pediatric Post-Traumatic Stress Disorder With Nightmares and/or Sleep Disorder: Case Series of 18 Patients Prospectively Assessed.
    Ferrafiat V; Soleimani M; Chaumette B; Martinez A; Guilé JM; Keeshin B; Gerardin P
    Front Psychiatry; 2020; 11():724. PubMed ID: 32774309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans.
    Breen A; Blankley K; Fine J
    J Am Assoc Nurse Pract; 2017 Feb; 29(2):65-69. PubMed ID: 27977074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prazosin for the treatment of nightmares related to posttraumatic stress disorder: a review of the literature.
    Hudson SM; Whiteside TE; Lorenz RA; Wargo KA
    Prim Care Companion CNS Disord; 2012; 14(2):. PubMed ID: 22943034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
    Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
    J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazosin for Trauma Nightmares and Sleep Disturbances in Combat Veterans with Post-Traumatic Stress Disorder.
    Khazaie H; Nasouri M; Ghadami MR
    Iran J Psychiatry Behav Sci; 2016 Sep; 10(3):e2603. PubMed ID: 27822278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder.
    Peskind ER; Bonner LT; Hoff DJ; Raskind MA
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):165-71. PubMed ID: 12967060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.
    McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB
    J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F; Raskind MA
    J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
    Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
    Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of post-traumatic stress disorder and its associated nightmares: A survey of psychiatrists.
    Martin A; Kosari S; Peterson GM; Thomas J; Morris P; Naunton M
    J Clin Pharm Ther; 2021 Feb; 46(1):158-165. PubMed ID: 33026676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.